Proficent 10000 (HCG 10000iu)

Product Overview

n

Proficent 10000 is a pharmaceutical preparation that contains Human Chorionic Gonadotropin (HCG) at a strength of 10,000 International Units per vial. It is formulated for intramuscular or subcutaneous administration and is supplied in a sterile, lyophilized powder that must be reconstituted before use. The product is packaged in a single vial within a sealed box, and the manufacturer offers various pack sizes to accommodate different treatment regimens.

nn

What is Proficent 10000

n

Human Chorionic Gonadotropin, commonly abbreviated as HCG, is a glycoprotein hormone that mimics the action of luteinizing hormone (LH) in the body. In reproductive medicine, HCG is used to stimulate the final maturation of ovarian follicles and to trigger ovulation in women undergoing fertility treatment. Proficent 10000 provides a standardized dose of 10,000 IU, a level that has been studied in clinical protocols for assisted reproduction.

nn

Uses and Benefits

n

Proficent 10000 is indicated for the treatment of female infertility associated with anovulation or oligo‑ovulation. When combined with other ovulation‑inducing agents, it can improve the chances of successful ovulation and subsequent pregnancy. Benefits reported in clinical studies include an increased number of mature follicles, improved endometrial thickness, and higher clinical pregnancy rates when used according to evidence‑based regimens.

n

Clinical investigations have demonstrated that the addition of HCG to controlled ovarian stimulation protocols can increase the number of mature oocytes retrieved, which is a key factor in improving embryo quality and implantation rates. Moreover, the standardized 10,000 IU dose of Proficent 10000 has been shown to produce consistent hormonal responses across diverse patient populations, facilitating reproducible outcomes in assisted reproduction cycles.

nn

How It Works

n

The mechanism of action of HCG involves binding to LH receptors on ovarian cells, thereby stimulating the production of cyclic adenosine monophosphate (cAMP) and activating downstream signaling pathways that promote steroidogenesis and follicular growth. By doing so, HCG accelerates the final stages of oocyte maturation and prepares the follicle for rupture, which is essential for natural or assisted conception.

n

Pharmacokinetic studies indicate that after subcutaneous administration, peak plasma concentrations of HCG are reached within 6 to 12 hours, and the drug exhibits linear absorption characteristics at therapeutic doses. The elimination of HCG occurs primarily through renal clearance, with a terminal half‑life that supports sustained receptor activation. Comparative data suggest that HCG offers a more favorable safety profile in terms of reduced risk of excessive androgenic activity when contrasted with certain synthetic gonadotropins.

nn

Dosage Guidelines

n

Dosage of Proficent 10000 must be individualized by a qualified healthcare professional based on the patient’s medical history, response to previous therapy, and the specific protocol employed by the fertility clinic. In many assisted reproductive technology (ART) protocols, a single 10,000 IU injection is administered when follicular size reaches a predetermined threshold, typically after stimulation with gonadotropin medications.

n

Patients should be advised that the exact timing of administration, the route of injection, and any supplemental medications are determined by the treating physician. It is essential to follow the prescribed schedule and to attend regular monitoring appointments, which may include ultrasound examinations and hormone level assessments, to ensure safe and effective use.

nn

Side Effects

n

Like all medicinal products, Proficent 10000 can be associated with adverse effects. The most commonly reported side effects include mild abdominal discomfort, bloating, injection site reactions such as redness or swelling, and headache. Less frequent but clinically significant events may involve ovarian hyperstimulation syndrome (OHSS), which requires prompt medical attention.

n

Management of ovarian hyperstimulation syndrome involves close monitoring of serum estradiol levels, serial ultrasound examinations, and adjustment of subsequent treatment cycles. Early recognition of symptoms such as abdominal distension, nausea, and reduced urine output allows clinicians to intervene promptly with supportive measures, including fluid management and cancellation of the current cycle if necessary. Long‑term safety data have not identified carcinogenic potential of HCG, but ongoing surveillance continues to inform regulatory guidance.

nn

Warnings and Precautions

n

Proficent 10000 should not be used in individuals with a known hypersensitivity to HCG or any of the excipients in the formulation. Caution is advised in patients with a history of hormone‑sensitive cancers, thromboembolic disorders, or uncontrolled thyroid disease.

n

Prior to initiating therapy, a baseline pregnancy test is recommended to exclude existing pregnancy, as HCG administration during an undiagnosed gestation could pose theoretical risks. Women of child‑bearing age should employ effective contraception until a negative pregnancy test is confirmed after discontinuation of treatment. Additionally, patients with a history of thromboembolic events should be evaluated carefully, as hormonal manipulations can influence coagulation pathways.

n

It is recommended that women who are pregnant or breastfeeding avoid the use of Proficent 10000, as the safety of HCG during these conditions has not been established.

nn

Frequently Asked Questions

n

n
1. Question: What is the purpose of Proficent 10000 in fertility treatment?
   Answer: Proficent 10000 provides a standardized dose of HCG to trigger final follicular maturation and ovulation, thereby increasing the likelihood of conception in women with ovulatory disorders.

n

2. Question: How should the medication be stored?
   Answer: The lyophilized powder should be kept at controlled room temperature, protected from light and moisture. Once reconstituted, the solution can be stored for a limited period as specified in the product label, typically up to 24 hours at refrigerator temperatures.

n

3. Question: Are there any dietary restrictions while using Proficent 10000?
   Answer: No specific dietary restrictions are required; however, maintaining a balanced diet and adequate hydration may support overall reproductive health during treatment.

n

4. Question: Can Proficent 10000 be used in combination with other fertility drugs?
   Answer: Yes, it is often used alongside gonadotropins or other ovulation‑inducing agents, but the exact combination and timing must be determined by a fertility specialist.

n

5. Question: Where can I find more detailed prescribing information?
   Answer: The full prescribing information, including contraindications and detailed adverse reaction reporting, is available on the manufacturer’s website and can be accessed through regulatory databases such as the FDA’s Drugs@FDA database.

n

n

For additional scientific resources, consult reputable medical repositories such as the National Center for Biotechnology Information, the U.S. Food and Drug Administration (FDA), or MedlinePlus.

n